{
  "meta": {
    "title": "Hepatobiliary_Disorders_Part_1",
    "url": "https://brainandscalpel.vercel.app/hepatobiliary-disorders-part-1-664b2bbf.html",
    "scrapedAt": "2025-11-30T11:13:03.930Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Abnormal variant hepatitis C</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Superimposed hepatitis E infection</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis A infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man has had long-standing jaundice, malaise and poor appetite. Over the past 6 months, he has lost 12kg in weight. On examination, he has palmar erythema, jaundiced sclera, spider naevi, hepatomegaly and ascites.<br>His blood investigations reveal:<br>Bilirubin 2.5 mg/dl<br>ALT: 150 U/l<br>ALP: 240 U/l<br>Hep C core antibody Positive<br>HBsAg: Negative<br>Hep A antibody Negative<br>What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196782",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196782,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<p>This patient has features of chronic liver disease, as evidenced by the presence of ascites and spider angiomas. However, an acute infection with Hepatitis E or C will cause SGPT elevation of the order of 1000. Hence, the most probable cause here is HCC.</p>\n<p><strong>Risk Factors for Hepatocellular Carcinoma (HCC):</strong></p>\n<ul>\n<li><strong>Cirrhosis</strong> is the leading risk factor for HCC.</li>\n<li>Cirrhosis results from <strong>chronic liver damage</strong> due to <strong>inflammation and fibrosis</strong>, regardless of the underlying cause.</li>\n<li>It is associated with nearly <strong>80% of HCC cases worldwide</strong>.</li>\n<li>Common causes of cirrhosis that contribute to HCC include:\n<ul>\n<li>Chronic Hepatitis B (HBV) infection</li>\n<li>Chronic Hepatitis C (HCV) infection</li>\n<li>Chronic alcohol consumption</li>\n<li>Metabolic syndrome (including non-alcoholic fatty liver disease)</li>\n<li>Hereditary hemochromatosis, especially with HFE1 gene mutations</li>\n</ul>\n</li>\n</ul>\n<p><strong>Hepatitis C (Option A)</strong> itself can lead to chronic liver disease and cirrhosis, but \"abnormal variant\" is <strong>not a standard diagnostic category</strong>. Chronic HCV does not explain the acute deterioration with weight loss and ascites alone unless there's a complication like <strong>HCC</strong> or decompensated cirrhosis.</p>\n<p><strong>Hepatitis E</strong> <strong>superinfection (Option B)</strong> is more common and severe in pregnant women and immunocompromised individuals. It causes acute hepatitis, not chronic features like palmar erythema, spider naevi, or ascites. No lab evidence of Hepatitis E is mentioned.</p>\n<p><strong>Hepatitis A (Option D)</strong> causes acute, self-limiting hepatitis and is not chronic. The patient has negative Hep A antibodies, ruling out recent or past infection.</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Venesection</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemodialysis</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver transplant</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man presents with an 8-month history of lethargy, joint pains, and jaundice. Over the next 4 years, he develops diabetes mellitus and is noted to have skin hyperpigmentation. Liver biopsy: Shows typical pre-cirrhotic changes.<br>Laboratory evaluation reveals:<br>Iron saturation: 93.4%<br>Serum ferritin: 1050 &mu;g/L<br>What is the first line of management?</span></p>",
      "unique_key": "DT1196784",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196784,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The first line management of haemochromatosis is therapeutic <strong>phlebotomy</strong> or <strong>venesection</strong>.</p>\n<ul>\n<li>Treatment in hemochromatosis aims to remove excess body iron and prevent progression to organ damage, especially liver cirrhosis, diabetes, and cardiomyopathy.</li>\n</ul>\n<p>This can be achieved in 2 ways:</p>\n<ul>\n<li><strong>Phlebotomy</strong>: <strong>First-line treatment</strong>; 500 mL weekly or twice weekly, continued until ferritin levels drop to &lt;100 &mu;g/L.\n<ul>\n<li><strong>Duration</strong>: Up to 1-2 years for advanced overload.</li>\n<li>~200-250 mg of iron removed.</li>\n</ul>\n</li>\n<li><strong>Chelation</strong>:\n<ul>\n<li>Parenteral iron chelators like deferoxamine can eliminate approximately 10-20 mg of iron daily, which is significantly less effective compared to the amount removed through weekly phlebotomy. <strong>(Option D)</strong></li>\n</ul>\n</li>\n<li>Phlebotomy remains the preferred option for most individuals as it is more cost-effective, convenient, and generally safer.</li>\n<li>However, in cases where phlebotomy is not feasible-such as in patients with significant anaemia or low protein levels-chelation therapy becomes necessary.</li>\n<li>The most effective way to administer deferoxamine is via subcutaneous infusion using a portable pump.</li>\n</ul>\n<p><strong>Additional Management Points:</strong></p>\n<ul>\n<li>Avoid:\n<ul>\n<li>Iron supplements</li>\n<li>Vitamin C supplements: can increase iron absorption.</li>\n<li>Alcohol (increases cirrhosis risk)</li>\n</ul>\n</li>\n<li>Monitor and treat complications: diabetes, heart disease, and hypogonadism as needed</li>\n<li>Chelation therapy (e.g., deferoxamine) is reserved for patients who cannot tolerate phlebotomy due to anaemia or other reasons</li>\n</ul>\n<p><strong>Hemodialysis(Option B)</strong>: Not indicated; iron overload is not managed through dialysis.</p>\n<p><strong>Liver</strong> <strong>Transplant (Option C)</strong>: Only considered in end-stage liver failure or decompensated cirrhosis-not first-line.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin saturation</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum ferritin</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 43-year-old man is being investigated for a 3-year history of arthralgia. On examination, his skin colour was normal, and there was no evidence of jaundice or hepatomegaly. He has the following lab results:<br>Alanine aminotransferase 35 U/L<br>Aspartate aminotransferase 40 U/L<br>Fasting plasma glucose 126 mg/dl<br>Ferritin 500 ug/L (15-300)<br>Which one of the following is the first-line screening investigation?</span></p>",
      "unique_key": "DT1196792",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196792,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The first-line screening investigation for haemochromatosis is <strong>transferrin saturation</strong>.</p>\n<ul>\n<li>Several tests are used to evaluate total body iron overload in suspected <strong>hereditary hemochromatosis (HH)</strong>.</li>\n<li>The goal is to assess iron levels, organ involvement (especially the liver), and confirm the genetic basis of the disease.</li>\n<li>The key investigations include:\n<ul>\n<li><strong>Serum Transferrin Saturation and Serum Iron</strong>\n<ul>\n<li><strong>First-line</strong> screening test. <strong>(Option A)</strong></li>\n<li>Transferrin saturation &gt;50% is a sensitive marker of increased iron absorption.</li>\n<li>Serum iron levels are typically elevated (&gt;300 &micro;g/dL).</li>\n</ul>\n</li>\n<li><strong>Serum Ferritin (Option C ruled out)</strong>\n<ul>\n<li>Reflects total body iron stores.</li>\n<li>Levels &gt;1000 &micro;g/L suggest significant iron overload, especially when combined with abnormal LFTs.</li>\n<li>Used to monitor response to therapy.</li>\n</ul>\n</li>\n<li><strong>Genetic Testing (HFE Mutation Assay)</strong>\n<ul>\n<li><strong>C282Y homozygosity</strong> is the most common mutation in hereditary hemochromatosis.</li>\n<li>Confirms diagnosis noninvasively.</li>\n<li>Especially useful when ferritin and transferrin saturation are elevated.</li>\n</ul>\n</li>\n<li><strong>MRI of the Liver (Option B ruled out)</strong>\n<ul>\n<li>Non-invasive assessment of hepatic iron content.</li>\n<li>Useful to estimate liver iron concentration when liver biopsy is not feasible.</li>\n</ul>\n</li>\n<li><strong>Liver Biopsy (Option D ruled out)</strong>\n<ul>\n<li>No longer first-line.</li>\n<li>Reserved for patients with unclear diagnosis (e.g., negative genetic testing), ferritin &gt;1000 &micro;g/L, or abnormal liver function tests.</li>\n<li>Helps evaluate the extent of fibrosis or cirrhosis.</li>\n</ul>\n</li>\n<li><strong>Deferoxamine Challenge Test</strong>\n<ul>\n<li>Used historically as a diagnostic aid: iron excretion &gt;2 mg/24 h after IM deferoxamine suggests iron overload.</li>\n<li>Rarely needed today due to better non-invasive options.</li>\n</ul>\n</li>\n<li><strong>Retrospective Iron Quantification via Phlebotomy</strong>\n<ul>\n<li>Calculating the total iron removed until ferritin normalises (1 mL blood = ~0.5 mg iron) helps confirm the degree of overload.<br /> <br /> </li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Dubin-Johnson syndrome</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Constrictive pericarditis</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Budd-Chiari syndrome</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old woman presents with sudden onset of right upper quadrant pain, jaundice, hepatomegaly, gross ascites, and bilateral ankle oedema. Symptoms began 5 weeks ago with rapid abdominal distension, pain, nausea, and vomiting. She is afebrile (37.1&deg;C), with clear lungs and normal JVP. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196797",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196797,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Budd-Chiari syndrome is a condition induced by thrombotic or nonthrombotic obstruction to hepatic venous outflow. The classic clinical triad of abdominal pain, hepatomegaly, and ascites is seen in BCS.</p>\n<ul>\n<li>The syndrome most often occurs in patients with underlying <strong>thrombotic diathesis</strong>, including\n<ul>\n<li>Myeloproliferative disorders, such as polycythemia vera</li>\n<li>Paroxysmal nocturnal hemoglobinuria</li>\n<li>Pregnancy</li>\n<li>Tumors</li>\n<li>Chronic inflammatory diseases</li>\n<li>Clotting disorders</li>\n<li>Tumors</li>\n</ul>\n</li>\n<li><strong>Doppler ultrasonography</strong> is the most effective primary initial <strong>screening </strong>method.</li>\n<li>CT and magnetic resonance angiography are both more sensitive than ultrasonography.</li>\n<li>The <strong>gold standard </strong>for diagnosis is <strong>hepatic venography</strong>, which should be performed when there is a high index of clinical suspicion and the results of noninvasive testing are either equivocal or negative.</li>\n</ul>\n<p><strong>Dubin-Johnson syndrome (Option A)</strong> is a disorder of bilirubin excretion that results in isolated conjugated hyperbilirubinemia</p>\n<p><strong>Constrictive pericarditis</strong> <strong>(Option B) </strong>presents with ascites followed by lower limb oedema; however, insidious in onset and gradually progressive. JVP is elevated due to increased right-sided filling pressures.</p>\n<p><strong>Lymphoma (Option D)</strong> is likely to present with constitutional features like fever, night sweats and weight loss that develop gradually.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Ursodeoxycholic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman has noticed mild jaundice, worsening joint pains and is complaining of itching on her skin for the past 8 months. On examination, she has palpable hepatomegaly and a bronze pigmentation on her skin. Her liver function tests show a bilirubin of 1.5 mg/dl, ALT 100 U/l, and ALP 480 U/l. ANA is negative, and anti-mitochondrial antibody is positive at 1:320. Which of the following medications is helpful?</span></p>",
      "unique_key": "DT1196798",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196798,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The clinical scenario here shows primary biliary cholangitis.</p>\n<p><strong>Management of primary biliary cholangitis:</strong></p>\n<ul>\n<li><strong>First-Line Treatment-Ursodeoxycholic Acid (UDCA):</strong>\n<ul>\n<li>Given at 13-15 mg/kg/day</li>\n<li>Slows disease progression, improves liver enzymes and histological features</li>\n<li>Most effective when started early, before cirrhosis develops</li>\n<li>Usually well tolerated</li>\n<li>Rare side effects: worsening of pruritus, diarrhoea, headache</li>\n</ul>\n</li>\n<li><strong>Non-responders to UDCA:</strong>\n<ul>\n<li>30-40% of patients may not respond adequately</li>\n<li>Obeticholic acid can help about half of these cases</li>\n</ul>\n</li>\n<li><strong>Symptom Management:</strong>\n<ul>\n<li>Pruritus<strong>:</strong>\n<ul>\n<li>Treated with cholestyramine, rifampin, naltrexone, or antihistamines</li>\n<li>Severe, resistant cases may require plasmapheresis</li>\n</ul>\n</li>\n<li>Fatigue<strong>:</strong>\n<ul>\n<li>No definitive treatment; frequent rest and naps may help</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Bone Health:</strong>\n<ul>\n<li><strong>Cholestatic liver diseases like PBC are associated with metabolic bone disorders</strong>, particularly:\n<ul>\n<li>Osteopenia</li>\n<li>Osteoporosis</li>\n<li>Osteomalacia</li>\n</ul>\n</li>\n<li>Bone density testing is advised</li>\n<li>Oral calcium and vitamin D supplementation are recommended</li>\n<li>Bisphosphonates are started if bone disease is found</li>\n</ul>\n</li>\n<li><strong>Long-term Care:</strong>\n<ul>\n<li>Regular follow-up with a specialist is essential</li>\n<li>Liver transplant may be necessary in advanced cases or liver failure</li>\n</ul>\n</li>\n</ul>\n<p><strong>Desferrioxamine (Option A):</strong> Used for iron overload, not indicated in PBC</p>\n<p><strong>Prednisolone (Option B):</strong> Indicated for autoimmune hepatitis, not PBC</p>\n<p><strong>Propranolol (Option C):</strong> Used to manage complications of portal hypertension, not primary therapy for PBC</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute hepatitis B infection</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Remote Hep B infection from which he has recovered</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcoholic liver disease</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic hepatitis B infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 51-year-old male presents with general weakness. He drinks approximately 20 units of alcohol each week and smokes 10 cigarettes daily. Examination reveals jaundice, numerous spider naevi, and he has a temperature of 37.5&deg;C. Abdominal examination reveals hepatosplenomegaly. Investigations show:<br>1. Bilirubin:12 mg/dl<br>2. ALP: 525 iu/l (45-105)<br>3. AST: 178 iu/l (1-31), Albumin 28 g/L (37-49)<br>4. HBsAg-negative<br>5. HBeAg-negative<br>6. anti-HBe-positive<br>7. IgG anti-HBc-positive<br>8. HBV DNA - undetectable<br>What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196817",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196817,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient's serology shows evidence of <strong>prior natural infection with hepatitis B</strong> that has resolved.</p>\n<p>The immune system has cleared the virus, as shown by the absence of HBsAg and HBV DNA, and presence of <strong>IgG anti-HBc</strong> and <strong>anti-HBe</strong>.</p>\n<p>Therefore, the correct diagnosis is <strong>remote hepatitis B infection from which the patient has recovered.</strong></p>\n<ul>\n<li>In a patient with acute hepatitis B, HBsAg will be positive, and HBeAg will be positive as the patient will be highly infectious.</li>\n<li>Shortly after the HBsAg appears, IgM anti-HBc antibody also appears.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024071261af8a2f-5247-4129-8bf9-9c9e1dae113b.jpg\"></li>\n<li>Subsequent serological changes depend on the patient's immune response.</li>\n<li>In individuals whose immune system successfully clears the hepatitis B virus, the <strong>HBsAg (Hepatitis B surface antigen)</strong> disappears as the infection resolves. This is followed by the appearance of <strong>anti-HBs antibodies</strong>, which indicate immunity.</li>\n<li>Simultaneously, <strong>IgM anti-HBc</strong>, which is present during the acute phase, is gradually replaced by <strong>IgG anti-HBc</strong>, a marker of past infection. In addition, <strong>anti-HBe antibodies</strong> emerge, reflecting viral clearance and reduced infectivity.</li>\n<li>In those cases where the body is unable to contain the infection, the patient goes for chronicity. Here, the HBsAg will be positive; there will be IgG Anti-HBc. The HBe can be positive or negative, just indicating the level of infectivity.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240712124c4c31-b287-4a30-a718-cad28069a2d8.jpg\">",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Ocreotide</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatostatin</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Carvedilol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old man presents with 2 bowls full of haematemesis. He drinks 10 pints of beer a day and has done so for 10 years. Upper GI endoscopy reveals oesophageal varices. Which of the following is effective in reducing the rates of rebleeding in the future?</span></p>",
      "unique_key": "DT1196818",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196818,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Beta blockers (propanolol, nadolol) are used for reducing rebleeding in oesophageal varices.</p>\n<p><strong>Primary Prophylaxis (Before First Bleed)</strong></p>\n<ul>\n<li>Who needs screening: All patients with cirrhosis should undergo upper GI endoscopy at diagnosis.</li>\n<li>Follow-up endoscopy:\n<ul>\n<li>Every 2 years, if liver disease is active.</li>\n<li>Every 3 years if inactive (e.g., after alcohol cessation or hepatitis cure).</li>\n<li>At any episode of decompensation.</li>\n</ul>\n</li>\n<li>When to start prophylaxis:\n<ul>\n<li>Medium or large varices.</li>\n<li>Small varices with high-risk features.</li>\n<li>Decompensated cirrhosis with varices.</li>\n</ul>\n</li>\n<li>Options for primary prevention:\n<ul>\n<li>Non-selective beta-blockers (NSBB): e.g., propranolol or nadolol. Goal: HR 55-60 bpm, SBP &gt; 90 mmHg.</li>\n<li>Endoscopic variceal ligation (EVL): equally effective.</li>\n<li><strong>Carvedilol</strong>: NSBB + alpha-1 blocker; also effective. <strong>(Option D ruled out)</strong></li>\n</ul>\n</li>\n<li>No surveillance endoscopy is needed once effective prophylaxis has been started.</li>\n</ul>\n<p><strong>Management of Acute Variceal Bleeding</strong></p>\n<ul>\n<li>Stabilization:\n<ul>\n<li>IV fluids and blood transfusions as needed.</li>\n<li>Restrictive transfusion target: Haemoglobin &lt;7 g/dL, with goal Hb 7-9 g/dL.</li>\n</ul>\n</li>\n<li>Pharmacologic therapy:\n<ul>\n<li>Vasoconstrictors: <strong>Somatostatin</strong> or <strong>octreotide</strong> to reduce portal pressure. <strong>(Options A &amp; C ruled out)</strong></li>\n<li>Prophylactic antibiotics: IV ceftriaxone before endoscopy to reduce infection, rebleeding, and mortality.</li>\n</ul>\n</li>\n<li>Endoscopic therapy:\n<ul>\n<li>Urgent upper GI endoscopy: diagnostic and therapeutic (usually EVL).</li>\n<li>If bleeding varices are gastric or unapproachable by banding &rarr; consider TIPS.</li>\n</ul>\n</li>\n<li>Balloon tamponade (e.g., Sengstaken-Blakemore tube):\n<ul>\n<li>Temporary measure for unstable patients before endoscopy or TIPS.</li>\n</ul>\n</li>\n<li>TIPS (Transjugular Intrahepatic Portosystemic Shunt):\n<ul>\n<li>Indicated if bleeding cannot be controlled with endoscopy.</li>\n<li>Risks: Hepatic encephalopathy (esp. in elderly or those with prior HE).</li>\n<li>Can be a bridge to liver transplant.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Prevention of Rebleeding (Secondary Prophylaxis)</strong></p>\n<ul>\n<li>Goal: Prevent recurrence of life-threatening bleeds.</li>\n<li>Combination therapy:\n<ul>\n<li>Repeated EVL: until varices are obliterated.</li>\n<li>Non-selective beta-blockers: e.g., propranolol or nadolol, to maintain portal pressure control.</li>\n</ul>\n</li>\n<li>If rebleeding occurs despite therapy:\n<ul>\n<li>TIPS is indicated for definitive management.</li>\n</ul>\n</li>\n<li>Monitoring after TIPS:\n<ul>\n<li>No further endoscopy needed.</li>\n<li>Regular Doppler ultrasound to assess TIPS patency and detect stenosis.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">CT of the abdomen</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Colonoscopy</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopy</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver function tests</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old man has a diagnosis of Ulcerative Colitis. He was incidentally found to have positive anti-smooth muscle antibodies by the family doctor who sent an autoimmune screen.<br>Which is the next recommended test for this patient?</span></p>",
      "unique_key": "DT1196819",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196819,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Anti-smooth muscle antibodies (ASMA)</strong> are suggestive but <strong>not diagnostic</strong> of autoimmune hepatitis. To assess for <strong>subclinical or evolving </strong>autoimmune hepatitis, the <strong>next logical and non-invasive step</strong> is to check <strong>liver function tests (LFTs)</strong>.</p>\n<ul>\n<li><strong>LFT abnormalities</strong> in AIH typically include:\n<ul>\n<li><strong>Elevated AST and ALT</strong> (100-1000 IU/L range)</li>\n<li><strong>Normal to mildly elevated ALP</strong></li>\n<li><strong>Variable bilirubin</strong></li>\n<li><strong>Low albumin</strong> in advanced disease</li>\n<li><strong>Prolonged PT</strong> in severe or late-stage disease</li>\n</ul>\n</li>\n<li>These markers help determine whether there is <strong>active liver inflammation or damage</strong>, and guide the need for further evaluation, such as <strong>liver biopsy</strong>.</li>\n</ul>\n<p><strong>CT Abdomen (Option A)</strong>: Not a first-line test for liver disease unless looking for structural abnormalities or complications.</p>\n<p><strong>Colonoscopy (Option B)</strong>: The patient already has known UC - this test is not related to assessing liver autoimmunity.</p>\n<p><strong>Endoscopy (Option C)</strong>: Unrelated to AIH diagnosis unless there's upper GI bleeding or other concerning symptoms.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute reactivation of hepatitis B</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculous peritonitis</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcoholic liver disease decompensation</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Spontaneous bacterial peritonitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old man has chronic liver disease secondary to hepatitis. He complains of having had a depressive episode and feels tired and unwell. He reveals that he has had a bottle of wine a day for a week. On examination, he has gross abdominal distension. A peritoneal tap is done. Results from the tap show that it has albumin of 2.5g/dl, LDH of 320 U/l, RBS of 70 mg/dl and a white cell count of 700 per mm<sup>3</sup> (90% neutrophils). What is the diagnosis?</span></p>",
      "unique_key": "DT1196820",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196820,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Absolute neutrophil count &gt;250/mm<sup>3</sup> in ascitic fluid</strong> confirms the diagnosis of SBP</li>\n<li>Typically occurs in patients with <strong>cirrhosis and ascites</strong>, without an evident intra-abdominal source of infection</li>\n<li>Cultures may or may not yield bacteria (most commonly <strong> coli</strong>, <strong>Streptococci</strong>, or other gut flora)</li>\n</ul>\n<p><strong>Pathogenesis:</strong></p>\n<ul>\n<li>SBP results from <strong>bacterial translocation</strong> from the gut to the ascitic fluid via mesenteric lymph nodes</li>\n<li>This occurs due to impaired gut barrier function and immune dysfunction associated with portal hypertension and cirrhosis</li>\n</ul>\n<p><strong>Clinical Importance:</strong></p>\n<ul>\n<li>SBP may present with <strong>non-specific symptoms</strong> such as fatigue, confusion, or malaise, or even be asymptomatic<br /> A <strong>high index of suspicion</strong> is needed in any cirrhotic patient with ascites who deteriorates</li>\n<li>Prompt treatment with <strong>IV third-generation cephalosporins</strong> and <strong>intravenous albumin</strong> significantly reduces complications like renal failure and mortality</li>\n</ul>\n<p><strong>Treatment of SBP:</strong></p>\n<ul>\n<li>Empirical therapy: Start with a third-generation cephalosporin (e.g., cefotaxime) administered intravenously for 5 days.</li>\n<li>Albumin infusion: This reduces the risk of renal failure and improves overall survival.</li>\n</ul>\n<p><strong>Prevention of SBP:</strong></p>\n<ul>\n<li>In variceal bleeding, the risk of SBP increases significantly during an upper GI bleed. Prophylactic antibiotics (typically quinolones or ceftriaxone) should be administered in these patients.</li>\n<li>After recovery from SBP: Patients with a prior episode of SBP should receive long-term antibiotic prophylaxis (commonly a daily quinolone) to prevent recurrence.</li>\n</ul>\n<p><strong>Acute reactivation of hepatitis B (Option A): </strong>This would usually present with elevated liver enzymes, jaundice, or signs of acute hepatic failure, not neutropilic ascitic fluid.</p>\n<p><strong>Tuberculous peritonitis (Option B): </strong>Typically has lymphocyte-predominant ascitic fluid, with high protein, low glucose, and a more chronic onset.</p>\n<p><strong>Alcoholic liver disease decompensation (Option C)</strong>: May cause ascites and hepatic deterioration, but does not lead to high neutrophil count in ascitic fluid unless complicated by SBP, which is the actual diagnosis in this case.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-alcoholic fatty liver disease</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuroacanthocytosis</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic hepatitis</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old obese woman with type 2 diabetes, no history of alcohol use, medications, pruritus, or jaundice, presents with elevated ALT and AST levels. Examination reveals a smooth, 3 cm palpable hepatomegaly without xanthelasma or stigmata of chronic liver disease. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196821",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196821,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient presents with features typical of <strong>non-alcoholic fatty liver disease (NAFLD)-</strong>a condition often seen in individuals with <strong>obesity</strong> and <strong>type 2 diabetes</strong>, especially in the absence of alcohol intake.</p>\r\n<ul>\r\n<li>NAFLD includes a spectrum from simple <strong>hepatic steatosis</strong> (fat accumulation without inflammation or fibrosis) to <strong>non-alcoholic steatohepatitis (NASH)</strong>, which can progress to fibrosis or cirrhosis in some cases.</li>\r\n<li>The mildly raised liver enzymes (<strong>ALT and AST</strong>) and smooth, non-tender hepatomegaly suggest <strong>fat accumulation</strong> rather than active inflammation or malignancy.</li>\r\n<li>The <strong>absence of systemic signs</strong> like jaundice, pruritus, xanthelasma, or features of chronic liver disease makes other causes such as hepatitis or hepatocellular carcinoma less likely. <strong>(Option C &amp; D ruled out)</strong></li>\r\n<li>Therefore, in a diabetic, obese woman with these findings, <strong>NAFLD</strong> is the most likely diagnosis.</li>\r\n</ul>\r\n<p><strong>Neuroacanthocytosis (Option B): </strong>This is a rare, inherited neurological disorder associated with <strong>movement abnormalities</strong> (like chorea or dystonia), <strong>cognitive decline</strong>, and <strong>acanthocytes</strong> (abnormal red blood cells). Liver enzyme elevation and hepatomegaly are not typical features. This diagnosis is unrelated to the patient's presentation.</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Bile canaliculi</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrahepatic ducts</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic duct</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Common bile duct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old man has painless jaundice. He has pale stools and dark urine. On examination, he is deeply jaundiced and has scratch marks all over his body. On palpation of the abdomen, Courvoisier's sign is positive. Where is the level of biliary obstruction?</span></p>",
      "unique_key": "DT1196823",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196823,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient presents with <strong>painless jaundice</strong>, <strong>pale (acholic) stools</strong>, <strong>dark urine</strong>, <strong>generalised pruritus</strong>, and a <strong>palpable gallbladder (Courvoisier's sign)</strong>.</li>\n<li>These features are classic for <strong>obstructive jaundice</strong>, most commonly due to a <strong>malignant lesion at the level of the common bile duct</strong>, such as <strong>carcinoma of the head of the pancreas</strong> or <strong>cholangiocarcinoma</strong>.</li>\n</ul>\n<p><strong>Bile canaliculi (Option A)</strong>: Obstruction at the microscopic canaliculi level (e.g., in hepatitis) does not cause a palpable gallbladder or painless jaundice. It's usually associated with <strong>hepatocellular</strong> causes.</p>\n<p><strong>Intrahepatic ducts (Option B)</strong>: Intrahepatic cholestasis (e.g., primary biliary cholangitis) typically leads to <strong>pruritus and elevated ALP</strong>, but <strong>not Courvoisier's sign</strong> or a markedly distended gallbladder.</p>\n<p><strong>Hepatic duct (Option C)</strong>: A blockage here would affect one side of the biliary tree and is less likely to cause <strong>painless, complete obstructive jaundice</strong> with Courvoisier's sign.</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Spider naevi</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Jaundice</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Ascites</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Encephalopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old alcoholic patient presents with confusion and severe derangement of liver function. Upon examination, his MMSE score is 22/30. He has signs of spider naevi, jaundice and gross ascites. Which one of the following features defines fulminant acute hepatic failure?</span></p>",
      "unique_key": "DT1196827",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196827,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<p>Acute liver failure may be fulminant or subfulminant.</p>\n<ul>\n<li>The development of hepatic encephalopathy characterises fulminant hepatic failure within 8 weeks after the onset of acute liver injury.</li>\n<li>Coagulopathy (INR 1.5 or higher) is invariably present.</li>\n<li>Subfulminant hepatic failure occurs when these findings appear between 8 weeks and 6 months after the onset of acute liver injury and carries an equally poor prognosis.</li>\n<li>Acute-on-chronic liver failure refers to acute deterioration in liver function (often caused by infection) in a person with preexisting chronic liver disease.</li>\n<li>The most common causes are paracetamol overdose and viral hepatitis.</li>\n</ul>\n<p><strong>Spider naevi (Opinion A): </strong>These are signs of chronic liver disease, particularly due to estrogen excess. They are not a defining feature of acute hepatic failure.</p>\n<p><strong>Jaundice (Option B): </strong>While jaundice often accompanies liver failure, it is a nonspecific sign of liver dysfunction and does not define fulminant hepatic failure.</p>\n<p><strong>Ascites (Option C) </strong>suggests <strong>chronic liver disease or portal hypertension</strong>. It may be seen in <strong>acute-on-chronic</strong> liver failure, but it is <strong>not diagnostic</strong> of fulminant acute hepatic failure.</p>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis evaluation</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver biopsy</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholestyramine</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Ursodeoxycholic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old lady presents with intense pruritus in her third trimester of pregnancy. Clinically, there are no abnormalities apart from scratch marks. Investigations reveal: ALT 150 U/L, Alkaline phosphatase 320 U/L, and bilirubin 6 mg/dl. CBC is normal. What should be the next management step?</span></p>",
      "unique_key": "DT1196832",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient has intrahepatic cholestasis of pregnancy, and the first-line treatment is ursodeoxycholic acid.</p>\n<p><strong>Gallbladder and Liver Disorders in Pregnancy</strong></p>\n<p><strong>Pregnancy &amp; Gallbladder Disease:</strong></p>\n<ul>\n<li>Pregnancy increases the risk of <strong>cholelithiasis</strong> or worsens existing gallbladder issues.</li>\n<li>This is likely due to <strong>hormonal changes affecting bile and fat metabolism</strong>.</li>\n</ul>\n<p><strong>Intrahepatic Cholestasis of Pregnancy (ICP):</strong></p>\n<ul>\n<li>Typically occurs in the <strong>third trimester</strong>.</li>\n<li>Presents with <strong>intense pruritus</strong> (especially on palms and soles).</li>\n<li>Diagnosed by <strong>elevated serum bile acids</strong>, with or without raised liver enzymes.</li>\n<li><strong>Risks and Management:</strong>\n<ul>\n<li>ICP is associated with a higher risk of <strong>stillbirth</strong>.</li>\n<li>Requires <strong>increased fetal monitoring</strong>.</li>\n<li><strong>Planned delivery at 37 weeks</strong> is recommended to reduce risk.</li>\n</ul>\n</li>\n<li><strong>Treatment:</strong>\n<ul>\n<li><strong>Ursodeoxycholic acid (ursodiol)</strong> is used to relieve symptoms.</li>\n<li><strong>Alternatives (less preferred):</strong> Cholestyramine, high-dose steroids (in select cases) <strong>(Option C)</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Hepatitis evaluation (Option A): </strong>This may be considered if there were systemic symptoms (fever, fatigue, anorexia), or a more hepatocellular picture, but in <strong>isolated pruritus without systemic illness</strong>, and a typical ICP pattern, hepatitis workup is not the next immediate step.</p>\n<p><strong>Liver biopsy (Option B): </strong>Invasive and <strong>not indicated</strong> in a pregnant woman with classical features of ICP. Diagnosis is <strong>clinical + labs</strong>, not histological.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute tubular necrosis</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Spontaneous bacterial peritonitis</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatorenal syndrome</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man with chronic hepatitis C has nonspecific general deterioration. On examination, he has a temperature of 37.8&deg;C, pressure of 100/70 mmHg and is jaundiced.<br>His investigations reveal:<br>S. Na: 129 mmol/l<br>S. K: 4.2 mmol/l<br>S. Urea 60 mg/dl<br>S. Cr: 3.1 mg/dl<br>Bilirubun: 3.2 mg/dl<br>AST: 92 (10-40) U/l<br>ALP: 250 (50-120) U/l<br>Albumin: 3.0 (3.3-4.2) g/dl<br>Urine sodium: 15 mmol/l<br>What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196834",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Hepatorenal syndrome (HRS) is the development of renal dysfunction in patients with severe liver disease (acute or chronic) in the absence of any other identifiable causes of renal pathology.</p>\n<p><strong>Two types of HRS have been described</strong>:</p>\n<ul>\n<li><strong>Type 1 </strong>is mainly associated with acute liver failure or alcoholic cirrhosis, but it can develop in any other form of liver failure.\n<ul>\n<li>It is characterised by rapid deterioration of renal function, with a <strong>marked drop in creatinine clearance</strong> over 1 to 2 weeks.</li>\n<li><strong>Hyponatremia </strong>and <strong>hyperkalemia</strong> are usual findings.</li>\n</ul>\n</li>\n<li><strong>Type 2 </strong>is a more stable form.\n<ul>\n<li>It presents with a more gradual and stable decline in kidney function, reflected by a <strong>persistent</strong> <strong>rise in serum creatinine</strong>.</li>\n<li>It generally has a better prognosis compared to Type 1 HRS.</li>\n<li>Peritoneal dialysis, hemodialysis, and hemofiltration remain controversial because of their limited benefit.</li>\n<li>However, they are still employed by certain centres in patients awaiting liver transplantation.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Acute tubular necrosis (ATN)</strong> <strong>(Option A)</strong> typically presents with high urine sodium (&gt;40 mmol/L) due to tubular damage. This patient's low urine sodium argues against ATN.</p>\n<p><strong>Spontaneous bacterial peritonitis (SBP) (Option B) </strong>typically presents with fever, abdominal pain, and signs of peritoneal irritation, and diagnosis requires paracentesis showing elevated neutrophils in ascitic fluid. While SBP can precipitate HRS, there is no mention of ascites or peritoneal symptoms in this case, making SBP less likely as the primary diagnosis.</p>\n<p><strong>Hepatocellular carcinoma (HCC) (Option C)</strong> often presents with weight loss, abdominal mass, or sudden liver decompensation and is diagnosed via imaging and elevated alpha-fetoprotein. There is no mention of a mass, AFP levels, or suspicious imaging findings here, so HCC is not the best fit.</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Valproic acid</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Co-Amoxiclav</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs causes cholestasis?</span></p>",
      "unique_key": "DT1196840",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196840,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Co-amoxiclav (Augmentin) can cause hepatic/cholestatic drug-induced jaundice. A 4-week delay in symptoms is not uncommon.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250913f7a1371a-5134-44ed-ba9c-191c7f4d2b3b.png\">\n<br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509130a0ed13f-5a77-4530-80c5-46a2f9794ee2.png\">",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">High serum copper</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperalbuminemia</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Low serum ceruloplasmin</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced hepatic copper</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man presents with slurring of speech and unsteadiness. He has a coarse tremor in his hands and an ataxic, shuffling gait on examination. His blood tests show normal renal function. AST is 250 (1-30) U/l, ALP is 350 (1-250) U/l and bilirubin is 2.2 mg/dl. Which of the following is true about the investigative findings in this patient?</span></p>",
      "unique_key": "DT1196842",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196842,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The given clinical scenario points to the diagnosis of Wilson's disease, and the correct investigative finding in this case is the low serum ceruloplasmin.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509134aa2636f-0317-4898-8123-97e7e45010aa.png\">",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">AST</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilirubin</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Prothrombin time</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old man has a long history of alcohol use. He presents with tremors, hallucinations and has signs of chronic liver disease as well as ascites. A senior resident doctor assesses the status of chronic liver disease with the Child Pugh Classification. Which of the following is not one of the criteria used to assess severity?</span></p>",
      "unique_key": "DT1196847",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196847,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>AST is not used to assess the severity of liver disease as per the Child-Pugh classification.</p>\n<p>Child Pugh classification includes: (Mnemonic: A BEAP)</p>\n<ul>\n<li><strong>A</strong>lbumin <strong>(Option A)</strong></li>\n<li><strong>B</strong>ilirubin level <strong>(Option C)</strong></li>\n<li><strong>E</strong>ncephalopathy</li>\n<li><strong>A</strong>scites</li>\n<li><strong>P</strong>rothrombin time <strong>(Option D)</strong></li>\n</ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">EEG</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasound of abdomen</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Random blood sugar</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI brain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old chronic alcoholic is found on the street with a low consciousness level. His GCS is 3/15 on arrival in casualty. On examination, his BP is 110/65, and he is jaundiced. There is marked ascites, and he has 7 spider naevi. ECG shows atrial fibrillation with a ventricular rate of 120. Which is the most practical test to elucidate why he is unconscious?</span></p>",
      "unique_key": "DT1196856",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196856,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>In a patient with liver disease, it is important to exclude <strong>hypoglycemia</strong> as a cause of unconsciousness.</p>\n<ul>\n<li>In patients with chronic liver disease, particularly alcohol-induced cirrhosis, hypoglycemia is a known complication.</li>\n<li>The liver is crucial for maintaining blood glucose levels through glycogen breakdown and glucose production.</li>\n<li>In liver cirrhosis, especially with malnutrition and reduced glycogen reserves, this ability is severely impaired.</li>\n<li>Alcohol further inhibits glucose production by interfering with key metabolic pathways.</li>\n<li>As a result, individuals with liver damage are more vulnerable to low blood sugar levels, which can present as altered mental status or even coma.</li>\n<li>Given this patient's history of alcoholism, cirrhosis, and altered consciousness, checking the blood glucose level is a fast, accessible, and essential test to rule out hypoglycemia as a reversible cause of unconsciousness.</li>\n</ul>\n<p><strong>EEG (Option A)</strong> is useful in assessing seizure activity or encephalopathy, but it is not a first-line investigation for unexplained unconsciousness. It does not provide immediate or reversible information and takes time to perform and interpret.</p>\n<p><strong>Ultrasound of abdomen (Option B) </strong>While useful for assessing ascites, portal hypertension, or liver morphology, it doesn't explain an acute drop in consciousness. It is not an emergency investigation in this scenario and will not change immediate management.</p>\n<p><strong>MRI (Option D)</strong> is useful for evaluating structural brain pathology (e.g., stroke, tumor, infection), but it is time-consuming, expensive, and not the most practical initial test in an unconscious patient. Also, the clinical presentation and history point more toward metabolic causes than focal neurological lesions.</p>\n<p><strong>Reference</strong>:</p>\n<p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9845885/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC9845885/</a></p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan of the abdomen</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">ERCP</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">HCV RNA levels</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man has worsening jaundice and has deranged liver function tests, which have worsened over the last 3 months. He has positive IgG to hepatitis C. Which of the following investigations is most useful for management of the condition?</span></p>",
      "unique_key": "DT1196865",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196865,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient has <strong>chronic hepatitis C</strong>, as indicated by positive <strong>IgG anti-HCV antibodies</strong> and persistent liver dysfunction. For chronic hepatitis, particularly with signs of ongoing liver injury (e.g., worsening jaundice and LFTs), determining the <strong>extent of liver damage</strong> is essential in planning treatment.</p>\n<p>A <strong>liver biopsy</strong> gives direct histological information about two critical aspects:</p>\n<ul>\n<li><strong>Grade</strong> - This assesses <strong>ongoing inflammation</strong> and necrosis in the liver. It reflects the <strong>activity</strong> of the disease.</li>\n<li><strong>Stage</strong> - This measures the <strong>extent of fibrosis</strong>, i.e., how much scarring has occurred. This is key for determining if the patient has progressed to <strong>cirrhosis</strong>.</li>\n</ul>\n<p>The result of the biopsy helps:</p>\n<ul>\n<li>Assess disease severity.</li>\n<li>Guide the <strong>urgency and type of antiviral therapy</strong>.</li>\n<li>Provide a prognosis, especially if cirrhosis is developing.</li>\n</ul>\n<p>A <strong>CT scan (Option A)</strong> can detect <strong>gross structural changes</strong> in the liver (e.g., masses, ascites, or cirrhosis) but <strong>cannot assess the microscopic level of inflammation or fibrosis</strong>. In hepatitis C management, treatment decisions depend on the <strong>degree of liver inflammation and fibrosis</strong>, which CT cannot determine.</p>\n<p><strong>ERCP (Option B)</strong> is used to evaluate and treat <strong>biliary tree disorders</strong> such as choledocholithiasis, bile duct strictures, or pancreaticobiliary tumours.</p>\n<p><strong>HCV RNA testing (Option C)</strong> detects <strong>active viremia</strong>, confirming chronic infection.</p>\n<p>But this patient already has <strong>confirmed hepatitis C (IgG positive)</strong> and <strong>clinical worsening</strong>, so the RNA would only reconfirm what is already suspected.</p>",
      "correct_choice_id": 184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Dubin-Johnson syndrome</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Crigler-Najjar syndrome</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Gilbert's syndrome</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">B12 deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old man is well but jaundiced. His urine colour is normal. His liver function tests show a total bilirubin level of 3.2 mg/dL, an unconjugated bilirubin level of 2.8 mg/dL, an ALT level of 26 U/l, an AST level of 25 U/l, a GGT level of 40 U/L, and an ALP level of 80 U/l. CBC is unremarkable. Ultrasound scan of the abdomen shows normal parenchymal texture of the liver. Which diagnosis is most likely?</span></p>",
      "unique_key": "DT1196871",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196871,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The most likely diagnosis is Gilbert's syndrome.</p>\n<ul>\n<li>Gilbert's syndrome is a common inherited condition caused by reduced activity of the enzyme <strong>bilirubin UDP-glucuronosyltransferase (UDPGT)</strong>, which conjugates bilirubin in the liver.</li>\n<li>Due to this reduced activity (about 10-35% of normal), patients have <strong>mild, fluctuating unconjugated hyperbilirubinemia</strong>, especially during periods of stress, fasting, or illness.</li>\n<li>Total bilirubin levels are usually <strong>&lt;6 mg/dL</strong>, and liver enzymes remain <strong>normal</strong>, as in this case.</li>\n<li>The <strong>normal urine colour</strong> indicates the absence of conjugated bilirubin in the urine, further supporting unconjugated hyperbilirubinemia.</li>\n<li>Normal CBC and ultrasound help rule out hemolysis and structural liver disease, respectively.</li>\n</ul>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240404adf181ff-f743-46b1-989d-634dd63b3437.jpg\">\n<p><strong>Dubin-Johnson syndrome</strong> <strong>(Option A): </strong>This causes <strong>conjugated</strong> hyperbilirubinemia, not unconjugated. The patient's bilirubin profile does not fit.</p>\n<p><strong>Crigler-Najjar syndrome (Option B)</strong> Type I presents in neonates with very high bilirubin (&gt;20 mg/dL) and severe symptoms. Type II has levels &gt;6 mg/dL. This patient's levels are lower, and he is asymptomatic.</p>\n<p><strong>B12 deficiency</strong> <strong>(Option D): </strong>Can cause ineffective erythropoiesis and mild hemolysis, leading to unconjugated hyperbilirubinemia, but the <strong>CBC is normal</strong>, ruling this out.</p>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis A virus</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B virus</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis C virus</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis D virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old man from Thailand presented with abdominal pain and a mass in the right upper quadrant. He reported that he had been diagnosed with viral hepatitis several years previously.<br>Investigations showed:<br>Serum alpha-fetoprotein: 13,500 IU/L (< 10)<br>What is the most likely underlying viral infection?</span></p>",
      "unique_key": "DT1196876",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196876,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient has <strong>chronic viral hepatitis</strong> and now presents with <strong>hepatocellular carcinoma (hepatoma)</strong>.</li>\n<li>The <strong>likely underlying viral causes</strong> are either the <strong>hepatitis B virus (HBV)</strong> or the <strong>hepatitis C virus (HCV)</strong>.</li>\n<li><strong>HBV is more prevalent</strong> in the <strong>Far East</strong> compared to HCV. <strong>(Option C ruled out)</strong></li>\n<li>The patient's <strong>country of origin</strong> is the only clue provided, and it points toward a <strong>region with high HBV prevalence</strong>.</li>\n</ul>\n<p>Therefore, the <strong>most likely cause</strong> of the hepatoma in this patient is <strong>chronic HBV infection</strong>.</p>\n<p><strong>Hepatitis A virus (HAV) (Option A): </strong>HAV causes acute, self-limited hepatitis and does not lead to chronic infection or HCC. Therefore, it is not associated with hepatoma.</p>\n<p><strong>Hepatitis D virus (HDV) (Option D): </strong>Only occurs in co-infection or superinfection with HBV. Rarely is the primary cause of HCC.</p>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">It is associated with hypogammaglobulinemia</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">It may be associated with keratoconjunctivitis sicca</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">It rarely interferes with menstruation except in later stages</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">It rarely presents before 20 years of age</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one of the following statements is true of autoimmune hepatitis?</span></p>",
      "unique_key": "DT1196878",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196878,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Autoimmune hepatitis may be associated with keratoconjunctivitis sicca.</p>\n<p><strong>Autoimmune hepatitis (AIH)</strong></p>\n<p><strong>Autoimmune hepatitis (AIH)</strong> is a chronic inflammatory liver condition caused by a loss of immune tolerance to liver antigens, leading to hepatocellular injury.</p>\n<ul>\n<li>It <strong>most commonly affects young to middle-aged women</strong>, but it can occur at <strong>any age</strong>, including <strong>children and adolescents</strong>. (Option D ruled out)</li>\n<li>The <strong>presentation varies widely-</strong>some individuals may be asymptomatic with only abnormal liver enzymes, while others present with overt hepatitis or even signs of <strong>advanced liver disease</strong> such as cirrhosis.</li>\n</ul>\n<p><strong>Laboratory and Immunologic Profile:</strong></p>\n<ul>\n<li>A hallmark of the disease is <strong>polyclonal hypergammaglobulinemia</strong>, especially an increase in <strong>IgG levels</strong>, often exceeding 2.5 g/dL. <strong>(Option A ruled out)</strong></li>\n<li><strong>Aminotransferases (AST, ALT)</strong> are elevated, often between <strong>100-1000 IU/L</strong>, and levels may <strong>fluctuate</strong> with disease activity.</li>\n<li><strong>Serum bilirubin</strong> may be normal or moderately elevated (up to 10 mg/dL).</li>\n<li><strong>Albumin</strong> levels may be reduced in patients with active inflammation or cirrhosis.</li>\n<li><strong>Alkaline phosphatase</strong> is usually normal or only slightly elevated, but can occasionally be markedly raised, mimicking cholestatic disorders like <strong>primary biliary cholangitis</strong>.</li>\n<li><strong>Autoantibodies</strong> are commonly present, including <strong>antinuclear antibodies (ANA)</strong>, <strong>anti-smooth muscle antibodies (ASMA)</strong>, and occasionally <strong>anti-LKM</strong></li>\n</ul>\n<p><strong>Systemic and Extrahepatic Manifestations:</strong></p>\n<p>These symptoms involve organs and systems outside the liver and reflect the autoimmune nature of the disease:</p>\n<ul>\n<li><strong>Musculoskeletal and Connective Tissue</strong>\n<ul>\n<li>Arthralgia (joint pain)</li>\n<li>Occasional arthritis</li>\n<li>Fatigue and malaise (generalised systemic symptoms)</li>\n</ul>\n</li>\n<li><strong>Skin and Mucocutaneous Involvement</strong>\n<ul>\n<li>Maculopapular rashes</li>\n<li>Cutaneous vasculitis (inflammation of small skin blood vessels)</li>\n<li>Erythema nodosum (painful red nodules, typically on the shins)</li>\n<li>Acne</li>\n</ul>\n</li>\n<li><strong>Glandular and Reproductive</strong>\n<ul>\n<li><strong>Amenorrhea</strong> (absence of menstruation)-commonly seen in women with active disease <strong>(Option C ruled out)</strong></li>\n<li><strong>Sicca symptoms</strong>:\n<ul>\n<li><strong>Dry eyes</strong> (keratoconjunctivitis sicca)</li>\n<li><strong>Dry mouth</strong> (xerostomia)</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Hematologic and Renal</strong>\n<ul>\n<li>Anemia</li>\n<li>Azotemia (indicative of kidney involvement)</li>\n</ul>\n</li>\n<li><strong>Serosal and Gastrointestinal</strong>\n<ul>\n<li>Pleuritis (inflammation of the lung pleura)</li>\n<li>Pericarditis (inflammation of the pericardial sac)</li>\n<li>Colitis (bowel inflammation)</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal tuberculosis</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatorenal syndrome</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Mixed essential cryoglobulinemia</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Spontaneous bacterial peritonitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old man with chronic hepatitis C is admitted with general deterioration; he has no specific symptoms and is currently not receiving any treatment. On examination, he is generally unwell with a temperature of 37.4&deg;C, blood pressure of 130/72 mmHg and appears jaundiced with the presence of ascites. His investigations are as follows:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250913a9fe7720-ef23-45e0-9fa6-516b30a797b1.png\"><br>What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196888",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196888,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient most likely has <strong>mixed essential cryoglobulinemia </strong>due to chronic Hepatitis C, since there is significant proteinuria and renal dysfunction.</p>\n<p><strong>Evidence of Primary Renal Pathology</strong></p>\n<ul>\n<li>The patient has <strong>significant proteinuria</strong> and <strong>relative hypertension</strong>, both of which point toward an intrinsic renal disease.</li>\n<li>These findings <strong>do not align</strong> with a functional or prerenal cause like hepatorenal syndrome, where proteinuria is typically absent. <strong>(Option B ruled out)</strong></li>\n</ul>\n<p><strong>Association with Hepatitis C</strong></p>\n<ul>\n<li>Chronic <strong>Hepatitis C infection</strong> is commonly linked to <strong>mixed cryoglobulinemia</strong>.</li>\n<li>This immune complex-mediated condition can lead to <strong>mesangioproliferative glomerulonephritis</strong>, a form of intrinsic kidney disease.</li>\n<li>Clinical manifestations often include:\n<ul>\n<li><strong>Renal impairment</strong></li>\n<li><strong>Systemic vasculitis</strong> features: neuropathy, purpura, and possible thrombotic events</li>\n</ul>\n</li>\n</ul>\n<p><strong>Spontaneous bacterial peritonitis (SBP) and abdominal tuberculosis (Option A &amp; D): </strong>The serum-ascites albumin gradient (SAAG) is &gt;11 g/L, consistent with portal hypertension. There is no evidence of peritonitis or infection in the ascitic fluid. This makes <strong>spontaneous bacterial peritonitis (SBP) or abdominal tuberculosis</strong> less likely.</p>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}